Immune-mediated Necrotizing Myopathy Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Immune-mediated Necrotizing Myopathy Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune-mediated Necrotizing Myopathy Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune-mediated Necrotizing Myopathy Treatment Overall Market Size
2.1 Global Immune-mediated Necrotizing Myopathy Treatment Market Size: 2023 VS 2030
2.2 Global Immune-mediated Necrotizing Myopathy Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immune-mediated Necrotizing Myopathy Treatment Players in Global Market
3.2 Top Global Immune-mediated Necrotizing Myopathy Treatment Companies Ranked by Revenue
3.3 Global Immune-mediated Necrotizing Myopathy Treatment Revenue by Companies
3.4 Top 3 and Top 5 Immune-mediated Necrotizing Myopathy Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Immune-mediated Necrotizing Myopathy Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immune-mediated Necrotizing Myopathy Treatment Players in Global Market
3.6.1 List of Global Tier 1 Immune-mediated Necrotizing Myopathy Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Immune-mediated Necrotizing Myopathy Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immune-mediated Necrotizing Myopathy Treatment Market Size Markets, 2023 & 2030
4.1.2 Steroids
4.1.3 Immunosuppressant
4.1.4 Others
4.2 By Type - Global Immune-mediated Necrotizing Myopathy Treatment Revenue & Forecasts
4.2.1 By Type - Global Immune-mediated Necrotizing Myopathy Treatment Revenue, 2019-2024
4.2.2 By Type - Global Immune-mediated Necrotizing Myopathy Treatment Revenue, 2025-2030
4.2.3 By Type - Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immune-mediated Necrotizing Myopathy Treatment Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Immune-mediated Necrotizing Myopathy Treatment Revenue & Forecasts
5.2.1 By Application - Global Immune-mediated Necrotizing Myopathy Treatment Revenue, 2019-2024
5.2.2 By Application - Global Immune-mediated Necrotizing Myopathy Treatment Revenue, 2025-2030
5.2.3 By Application - Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Immune-mediated Necrotizing Myopathy Treatment Market Size, 2023 & 2030
6.2 By Region - Global Immune-mediated Necrotizing Myopathy Treatment Revenue & Forecasts
6.2.1 By Region - Global Immune-mediated Necrotizing Myopathy Treatment Revenue, 2019-2024
6.2.2 By Region - Global Immune-mediated Necrotizing Myopathy Treatment Revenue, 2025-2030
6.2.3 By Region - Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Immune-mediated Necrotizing Myopathy Treatment Revenue, 2019-2030
6.3.2 US Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.3.3 Canada Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.3.4 Mexico Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Immune-mediated Necrotizing Myopathy Treatment Revenue, 2019-2030
6.4.2 Germany Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.4.3 France Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.4.4 U.K. Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.4.5 Italy Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.4.6 Russia Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.4.8 Benelux Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Immune-mediated Necrotizing Myopathy Treatment Revenue, 2019-2030
6.5.2 China Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.5.3 Japan Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.5.4 South Korea Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.5.6 India Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Immune-mediated Necrotizing Myopathy Treatment Revenue, 2019-2030
6.6.2 Brazil Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.6.3 Argentina Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Revenue, 2019-2030
6.7.2 Turkey Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.7.3 Israel Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
6.7.5 UAE Immune-mediated Necrotizing Myopathy Treatment Market Size, 2019-2030
7 Immune-mediated Necrotizing Myopathy Treatment Companies Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Company Summary
7.1.2 GlaxoSmithKline plc Business Overview
7.1.3 GlaxoSmithKline plc Immune-mediated Necrotizing Myopathy Treatment Major Product Offerings
7.1.4 GlaxoSmithKline plc Immune-mediated Necrotizing Myopathy Treatment Revenue in Global Market (2019-2024)
7.1.5 GlaxoSmithKline plc Key News & Latest Developments
7.2 Dr. Reddy's Laboratories
7.2.1 Dr. Reddy's Laboratories Company Summary
7.2.2 Dr. Reddy's Laboratories Business Overview
7.2.3 Dr. Reddy's Laboratories Immune-mediated Necrotizing Myopathy Treatment Major Product Offerings
7.2.4 Dr. Reddy's Laboratories Immune-mediated Necrotizing Myopathy Treatment Revenue in Global Market (2019-2024)
7.2.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.3 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.)
7.3.1 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Company Summary
7.3.2 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Business Overview
7.3.3 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Immune-mediated Necrotizing Myopathy Treatment Major Product Offerings
7.3.4 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Immune-mediated Necrotizing Myopathy Treatment Revenue in Global Market (2019-2024)
7.3.5 Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Key News & Latest Developments
7.4 Hetero Drugs Limited
7.4.1 Hetero Drugs Limited Company Summary
7.4.2 Hetero Drugs Limited Business Overview
7.4.3 Hetero Drugs Limited Immune-mediated Necrotizing Myopathy Treatment Major Product Offerings
7.4.4 Hetero Drugs Limited Immune-mediated Necrotizing Myopathy Treatment Revenue in Global Market (2019-2024)
7.4.5 Hetero Drugs Limited Key News & Latest Developments
7.5 AbbVie Inc.
7.5.1 AbbVie Inc. Company Summary
7.5.2 AbbVie Inc. Business Overview
7.5.3 AbbVie Inc. Immune-mediated Necrotizing Myopathy Treatment Major Product Offerings
7.5.4 AbbVie Inc. Immune-mediated Necrotizing Myopathy Treatment Revenue in Global Market (2019-2024)
7.5.5 AbbVie Inc. Key News & Latest Developments
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Company Summary
7.6.2 Teva Pharmaceutical Industries Business Overview
7.6.3 Teva Pharmaceutical Industries Immune-mediated Necrotizing Myopathy Treatment Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Immune-mediated Necrotizing Myopathy Treatment Revenue in Global Market (2019-2024)
7.6.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Immune-mediated Necrotizing Myopathy Treatment Major Product Offerings
7.7.4 Novartis AG Immune-mediated Necrotizing Myopathy Treatment Revenue in Global Market (2019-2024)
7.7.5 Novartis AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Immune-mediated Necrotizing Myopathy Treatment Market Opportunities & Trends in Global Market
Table 2. Immune-mediated Necrotizing Myopathy Treatment Market Drivers in Global Market
Table 3. Immune-mediated Necrotizing Myopathy Treatment Market Restraints in Global Market
Table 4. Key Players of Immune-mediated Necrotizing Myopathy Treatment in Global Market
Table 5. Top Immune-mediated Necrotizing Myopathy Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Immune-mediated Necrotizing Myopathy Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Immune-mediated Necrotizing Myopathy Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Immune-mediated Necrotizing Myopathy Treatment Product Type
Table 9. List of Global Tier 1 Immune-mediated Necrotizing Myopathy Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune-mediated Necrotizing Myopathy Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Immune-mediated Necrotizing Myopathy Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Immune-mediated Necrotizing Myopathy Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Immune-mediated Necrotizing Myopathy Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Immune-mediated Necrotizing Myopathy Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Immune-mediated Necrotizing Myopathy Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Immune-mediated Necrotizing Myopathy Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2025-2030
Table 30. GlaxoSmithKline plc Company Summary
Table 31. GlaxoSmithKline plc Immune-mediated Necrotizing Myopathy Treatment Product Offerings
Table 32. GlaxoSmithKline plc Immune-mediated Necrotizing Myopathy Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. GlaxoSmithKline plc Key News & Latest Developments
Table 34. Dr. Reddy's Laboratories Company Summary
Table 35. Dr. Reddy's Laboratories Immune-mediated Necrotizing Myopathy Treatment Product Offerings
Table 36. Dr. Reddy's Laboratories Immune-mediated Necrotizing Myopathy Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Dr. Reddy's Laboratories Key News & Latest Developments
Table 38. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Company Summary
Table 39. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Immune-mediated Necrotizing Myopathy Treatment Product Offerings
Table 40. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Immune-mediated Necrotizing Myopathy Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Key News & Latest Developments
Table 42. Hetero Drugs Limited Company Summary
Table 43. Hetero Drugs Limited Immune-mediated Necrotizing Myopathy Treatment Product Offerings
Table 44. Hetero Drugs Limited Immune-mediated Necrotizing Myopathy Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Hetero Drugs Limited Key News & Latest Developments
Table 46. AbbVie Inc. Company Summary
Table 47. AbbVie Inc. Immune-mediated Necrotizing Myopathy Treatment Product Offerings
Table 48. AbbVie Inc. Immune-mediated Necrotizing Myopathy Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. AbbVie Inc. Key News & Latest Developments
Table 50. Teva Pharmaceutical Industries Company Summary
Table 51. Teva Pharmaceutical Industries Immune-mediated Necrotizing Myopathy Treatment Product Offerings
Table 52. Teva Pharmaceutical Industries Immune-mediated Necrotizing Myopathy Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Teva Pharmaceutical Industries Key News & Latest Developments
Table 54. Novartis AG Company Summary
Table 55. Novartis AG Immune-mediated Necrotizing Myopathy Treatment Product Offerings
Table 56. Novartis AG Immune-mediated Necrotizing Myopathy Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Novartis AG Key News & Latest Developments
List of Figures
Figure 1. Immune-mediated Necrotizing Myopathy Treatment Segment by Type in 2023
Figure 2. Immune-mediated Necrotizing Myopathy Treatment Segment by Application in 2023
Figure 3. Global Immune-mediated Necrotizing Myopathy Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Immune-mediated Necrotizing Myopathy Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Immune-mediated Necrotizing Myopathy Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immune-mediated Necrotizing Myopathy Treatment Revenue in 2023
Figure 8. By Type - Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 16. US Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 28. China Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Immune-mediated Necrotizing Myopathy Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Immune-mediated Necrotizing Myopathy Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. GlaxoSmithKline plc Immune-mediated Necrotizing Myopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Dr. Reddy's Laboratories Immune-mediated Necrotizing Myopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Genentech USA, Inc. (F. Hoffmann-La Roche Ltd.) Immune-mediated Necrotizing Myopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Hetero Drugs Limited Immune-mediated Necrotizing Myopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. AbbVie Inc. Immune-mediated Necrotizing Myopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Teva Pharmaceutical Industries Immune-mediated Necrotizing Myopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Novartis AG Immune-mediated Necrotizing Myopathy Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
